Xeris Chooses Alucio's Beacon Scientific Exchange Platform to
Enhance Medical Communications and Drive Innovation
SAN
FRANCISCO, July 15, 2024 /PRNewswire-PRWeb/ --
Alucio™, a fast-growing provider of cloud-based software for the
life sciences industry, today announced that Xeris Pharmaceuticals
("Xeris") has selected Alucio's Beacon scientific exchange platform
for use by its Medical Affairs and Field Medical teams.
"Beacon's modern capabilities will
complement our field medical team and support our continued focus
in advancing medical research and innovations," commented
Katie Chavanu, PharmD - VP, Medical
Communications & Regional Medical Affairs at Xeris.
Xeris is a growth-oriented biopharmaceutical company improving
patient lives by developing and commercializing advanced products
across a range of therapies. Alucio's core product, Beacon, is a
modern content activation and HCP engagement platform built
specifically for Medical Science Liaisons (MSLs), Medical Affairs
professionals and Market Access teams.
Through this partnership, Xeris will have access to Beacon's
modern, medical-specific CLM features. These include the platform's
powerful content library management and on-demand publishing
functionality to organize materials and distribute documents to
their field medical team. Beacon will also compliantly enable MSLs
to assemble custom presentations to meet the specific information
needs of healthcare professionals.
Additionally, Beacon's hybrid engagement functionality will
provide unique, purpose-built capabilities to enrich virtual
meetings across leading video conferencing platforms like Zoom. The
system will also power in-person meetings on tablets and laptops
where internet service is unavailable. Xeris MSLs will be able to
extend their HCP engagements post-meeting using the platform's
secure, online Beacon Hub feature.
"We are excited to have selected Beacon to help advance our
scientific exchange agility in Medical Affairs. Beacon's modern
capabilities will complement our field medical team and support our
continued focus in advancing medical research and innovations,"
commented Katie Chavanu, PharmD -
VP, Medical Communications & Regional Medical Affairs at
Xeris.
Xeris adds to Alucio's fast-growing roster of life science
companies that have become Beacon customers. The platform can
support both large and small pharma, biotech and medical device
companies seeking to better manage and distribute scientific
content, and to deepen their relationships with both medical key
opinion leaders and payers.
"We are thrilled to be working with Xeris to help achieve their
ambitious company goals and enhance their engagements with
healthcare professionals. We look forward to launching Beacon for
the Xeris Medical Affairs team and to supporting them every step of
the way to ensure their success," said Alucio Co-Founder and CRO,
Jeff Asada.
About Alucio:
Alucio is dedicated to the development of innovative software
applications specifically for the life sciences industry. Alucio's
flagship product, Beacon, is a modern, cloud-based scientific
exchange platform that enhances scientific dialogue and engagement
between life science companies and healthcare professionals. For
more information, please visit the company's website at
http://www.alucio.io or contact: Lisa
Amin at lamin@alucio.io (925) 788-3533.
Media Contact
Lisa Amin, Alucio, 925-788-3533,
lamin@alucio.io, https://www.alucio.io
View original content to download
multimedia:https://www.prweb.com/releases/alucio-adds-xeris-pharmaceuticals-to-its-growing-customer-base-302196472.html
SOURCE Alucio